Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2024-12-03 Director's Dealing
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2024-12-03 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(3) related to a registration statement under the Securities Act of 1933. It details the terms of a new debt offering by CVS Health Corporation, specifically the issuance of Series A and Series B Junior Subordinated Notes. The text includes detailed descriptions of the notes, interest rates, maturity dates, underwriting information, risk factors, and legal disclaimers. This type of document is a capital raising disclosure describing new securities issuance and financing terms. It is not an annual or quarterly report, audit report, earnings release, or any other type of report. It is clearly a financing update related to capital markets activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2024-12-03 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 2, 2024, by CVS Health Corporation. It announces the commencement of cash tender offers for various senior notes, which is a financing activity related to the company's debt instruments. The document includes a press release about the tender offers and does not contain detailed financial statements or comprehensive financial performance data. The primary content is an update on capital structure changes through tender offers. Therefore, this filing fits the category of Capital/Financing Update (CAP). The document length is 4008 characters, which is consistent with a typical 8-K announcement rather than a full report. Hence, the classification is CAP with high confidence.
2024-12-02 English
PRIMARY DOCUMENT
Director's Dealing
2024-11-26 English
PRIMARY DOCUMENT
Director's Dealing
2024-11-26 English
PRIMARY DOCUMENT
Director's Dealing
2024-11-26 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.